Search for a full or partial Catalog Number, CAS Number or description
CAS Number: 1314-13-2
Product Catalog
93-3017
Zinc › Zinc oxide, 99.7%| CAS Number: | 1314-13-2 |
| MDL Number: | MFCD00011300 |
| Molecular Formula: | OZn |
| Molecular Weight: | 81.37 |
| Chemical Formula: | ZnO |
| Color and Form: | white pwdr. (mean partical size 0.31 microns) |
| Note: |
Physical Characteristics: melting point 1975°C, density 5.606
| SECTION 1: Product Identification | |
|---|---|
| Chemical Name: | Zinc oxide, 99.7% |
| Product Number: | 93-3017 |
| CAS Registry Number: | 1314-13-2 |
| Formula: | ZnO |
| EINECS Number: | 215-222-5 |
| Chemical Family: | metal oxide |
| Synonym: | zinc monoxide |
| SECTION 2: Composition and Information on Ingredients | ||||
|---|---|---|---|---|
| Ingredient | CAS Number | Percent | ACGIH (TWA) | OSHA (PEL) |
| Title Compound | 1314-13-2 | 100 | 10mg/m3 | 15mg/m3 |
| SECTION 3: Hazards Identification | |
|---|---|
| Emergency Overview: | Irritating to skin, eyes and respiratory tract. Inhalation of high levels may produce symptoms known as metal fume fever or zinc shakes. |
| Primary Routes of Exposure: | Ingestion, Inhalation of dust. |
| Eye Contact: | Causes slight to mild irritation of the eyes. |
| Skin Contact: | Causes slight to mild irritation of the skin. |
| Inhalation: | Irritating to the nose, mucous membranes and respiratory tract. Inhalation may produce symptoms known as metal fume fever and zinc shakes. |
| Ingestion: | Zinc salts have a harsh metallic taste. |
| Acute Health Effects: | Irritating to eyes, skin and respiratory tract. Inhalation may cause chills, muscle aches, nausea, vomiting, fever, dry throat, cough, headache, blurred vision and decreased pulmonary function. |
| Chronic Health Effects: | Prolonged or repeated exposure may cause breathing difficulty and decreased pulmonary function. |
| NTP: | No |
| IARC: | No |
| OSHA: | No |
| SECTION 4: First Aid Measures | |
|---|---|
| Eye Exposure: | Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need assistance in keeping their eye lids open. Get immediate medical attention. |
| Skin Exposure: | Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if irritation persists. |
| Inhalation: | Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance. |
| Ingestion: | Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce vomiting only if directed by medical personnel. |
| SECTION 5: Fire Fighting Measures | |
|---|---|
| Flash Point: | not applicable |
| Autoignition Temperature: | none |
| Explosion Limits: | none |
| Extinguishing Medium: | None. Material is non-flammable. |
| Special Fire Fighting Procedures: | If involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure self-contained breathing apparatus and full protective clothing. |
| Hazardous Combustion and Decomposion Products: | No hazardous combustion or decomposition products. |
| Unusual Fire or Explosion Hazards: | No unusual fire or explosion hazards. |
| SECTION 6: Accidental Release Measures | |
|---|---|
| Spill and Leak Procedures: | Small spills can be mixed with vermiculite or sodium carbonate and swept up. |
| SECTION 7: Handling and Storage | |
|---|---|
| Handling and Storage: | Store in a tightly sealed container. |
| SECTION 8: Exposure Controls and Personal Protection | |
|---|---|
| Eye Protection: | Always wear approved safety glasses when handling a chemical substance in the laboratory. |
| Skin Protection: | Wear appropriate chemical resistant gloves and protective clothing. |
| Ventilation: | Material may form a fine dust. If possible, handle the material in an efficient fume hood. |
| Respirator: | If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134. |
| Additional Protection: | No additional protection required. |
| SECTION 9: Physical and Chemical Properties | |
|---|---|
| Color and Form: | white pwdr. (mean particle size 0.31 microns) |
| Molecular Weight: | 81.37 |
| Melting Point: | 1975°C |
| Boiling Point: | no data |
| Vapor Pressure: | not applicable |
| Specific Gravity: | 5.606 |
| Odor: | none |
| Solubility in Water: | insoluble |
| SECTION 10: Stability and Reactivity | |
|---|---|
| Stability: | air and moisture stable solid |
| Hazardous Polymerization: | no hazardous polymerization |
| Conditions to Avoid: | none |
| Incompatibility: | Strong mineral acids and bases. |
| Decomposition Products: | none |
| SECTION 11: Toxicological Information | |
|---|---|
| RTECS Data: | Administration onto the skin (rabbit); Standard Draize test: 500 mg/24H. Oral (human) LDLo: 500 mg/kg. Inhalation (human); TCLo: 600 mg/m3. Oral (rat); LD: >8437 mg/kg. Intraperitoneal (rat); LD50: 240 mg/kg. Oral (mouse); LD50: 7950 mg/kg. Inhalation (mouse); LC50: 2500 mg/m3. Oral (rat); TDLo: 17431 mg/kg/90D-C. Inhalation (guinea pig); TCLo: 5900 ug/m3/3H/3D-I. Inhalation (guinea pig); TCLo: 4600 ug/m3/3H/6D-I. Oral (chicken); TDLo: 32203 mg/kg/4W-C. Oral (mammal-domestic); TDLo: 3584 mg/kg/4W-I. Oral (rat); TDLo: 6846 mg/kg. Inhalation (rat); Cytogenetic analysis: 100 ug/m3. Hamster embryo; Morphological Transformation: 1 mg/L. |
| Carcinogenic Effects: | No data available |
| Mutagenic Effects: | Inconclusive data |
| Tetratogenic Effects: | Insufficient data |
| SECTION 12: Ecological Information | |
|---|---|
| Ecological Information: | Very toxic to aquatic organisms. |
| SECTION 13: Disposal Considerations | |
|---|---|
| Disposal: | Dispose of according to local, state and federal regulations. |
| SECTION 14: Transportation | |
|---|---|
| Shipping Name (CFR): | Non-hazardous |
| Hazard Class (CFR): | NA |
| Additional Hazard Class (CFR): | NA |
| Packaging Group (CFR): | NA |
| UN ID Number (CFR): | NA |
| Shipping Name (IATA): | Non-hazardous |
| Hazard Class (IATA): | NA |
| Additional Hazard Class (IATA): | NA |
| Packaging Group (IATA): | NA |
| UN ID Number (IATA): | NA |
| SECTION 15: Regulatory Information | |
|---|---|
| TSCA: | Listed in the TSCA inventory |
| SARA (Title 313): | Title compound: See Category Code N982 for reporting. |
| Second Ingredient: | none |
| Third Ingredient: | none |
| SECTION 16: Other Information | |
|---|---|
| Disclaimer: | The information herein is believed to be accurate and reliable as of the date compiled. However, Strem Chemicals, Inc. makes no representation, warranty, or guarantee of any kind with respect to the information contained in this document or any use of the product based on this information. |
| Preparation Date: | 3/20/2001 |
| Revision Date: | 12/14/2011 |
